Adherence-adjustment in placebo-controlled randomized trials: An application to the candesartan in heart failure randomized trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Adherence-adjustment in placebo-controlled randomized trials: An application to the candesartan in heart failure randomized trial

Published:2020-03 Issue: Volume:90 Page:105937
ISSN:1551-7144
Container-title:Contemporary Clinical Trials
language:en
Short-container-title:Contemporary Clinical Trials

Author:

Murray Eleanor J.,Claggett Brian L.,Granger Bradi,Solomon Scott D.,Hernán Miguel A.

Funder

Harvard T.H. Chan School Institutional Review Board

Patient-Centered Outcomes Research Institute

Publisher

Elsevier BV

Subject

Pharmacology (medical),General Medicine

Reference21 articles.

1. Beyond the intention-to-treat in comparative effectiveness research;Hernán;Clin. Trials,2012

2. Guidelines for estimating causal effects in pragmatic randomized trials;Murray,2019

3. Per-protocol analyses of pragmatic trials;Hernán;N. Engl. J. Med.,2017

4. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial;Granger;Lancet,2005

5. Treatment adherence and risk of death after a myocardial infarction;Horwitz;Lancet,1990

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Placebo Adherence as a Negative Control Exposure;Epidemiology;2024-07-05

2. Impact of angiotensin receptor-neprilysin inhibition (ARNI) in improving ejection fraction and left and right ventricular remodeling in heart failure;Current Problems in Cardiology;2024-04

3. Key considerations for choosing a statistical method to deal with incomplete treatment adherence in pragmatic trials;Pharmaceutical Statistics;2022-08-03

4. Considerations for choosing an imputation method for addressing sparse measurement issues dictated by the study design - An illustration from per-protocol analysis in pragmatic trials;Research Methods in Medicine & Health Sciences;2022-05-08

5. Contrasting approaches for addressing non-adherence in randomized controlled trials: An illustration from the REFLUX trial;Clinical Trials;2021-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3